These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 22619524)
1. Improving thermal stability and efficacy of BCNU in treating glioma cells using PAA-functionalized graphene oxide. Lu YJ; Yang HW; Hung SC; Huang CY; Li SM; Ma CC; Chen PY; Tsai HC; Wei KC; Chen JP Int J Nanomedicine; 2012; 7():1737-47. PubMed ID: 22619524 [TBL] [Abstract][Full Text] [Related]
2. Self-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomas. Yang HW; Hua MY; Liu HL; Huang CY; Tsai RY; Lu YJ; Chen JY; Tang HJ; Hsien HY; Chang YS; Yen TC; Chen PY; Wei KC Biomaterials; 2011 Sep; 32(27):6523-32. PubMed ID: 21645920 [TBL] [Abstract][Full Text] [Related]
3. The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas. Hua MY; Liu HL; Yang HW; Chen PY; Tsai RY; Huang CY; Tseng IC; Lyu LA; Ma CC; Tang HJ; Yen TC; Wei KC Biomaterials; 2011 Jan; 32(2):516-27. PubMed ID: 21030073 [TBL] [Abstract][Full Text] [Related]
4. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study. Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168 [TBL] [Abstract][Full Text] [Related]
5. Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study. Hamstra DA; Moffat BA; Hall DE; Young JM; Desmond TJ; Carter J; Pietronigro D; Frey KA; Rehemtulla A; Ross BD J Neurooncol; 2005 Jul; 73(3):225-38. PubMed ID: 15980973 [TBL] [Abstract][Full Text] [Related]
6. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model. Kim GY; Tyler BM; Tupper MM; Karp JM; Langer RS; Brem H; Cima MJ J Control Release; 2007 Nov; 123(2):172-8. PubMed ID: 17884232 [TBL] [Abstract][Full Text] [Related]
7. BCNU-loaded PEG-PLLA ultrafine fibers and their in vitro antitumor activity against Glioma C6 cells. Xu X; Chen X; Xu X; Lu T; Wang X; Yang L; Jing X J Control Release; 2006 Sep; 114(3):307-16. PubMed ID: 16891029 [TBL] [Abstract][Full Text] [Related]
8. AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain. Akilo OD; Choonara YE; Strydom AM; du Toit LC; Kumar P; Modi G; Pillay V Int J Pharm; 2016 Mar; 500(1-2):196-209. PubMed ID: 26806465 [TBL] [Abstract][Full Text] [Related]
9. A composite of graphene oxide and iron oxide nanoparticles for targeted drug delivery of temozolomide. Wang LH; Sui L; Zhao PH; Ma HD; Liu JY; Wei Z; Zhan ZJ; Wang YL Pharmazie; 2020 Jul; 75(7):313-317. PubMed ID: 32635972 [TBL] [Abstract][Full Text] [Related]
10. Folate-modified Graphene Oxide as the Drug Delivery System to Load Temozolomide. Wang LH; Liu JY; Sui L; Zhao PH; Ma HD; Wei Z; Wang YL Curr Pharm Biotechnol; 2020; 21(11):1088-1098. PubMed ID: 32101121 [TBL] [Abstract][Full Text] [Related]
11. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Ting CY; Fan CH; Liu HL; Huang CY; Hsieh HY; Yen TC; Wei KC; Yeh CK Biomaterials; 2012 Jan; 33(2):704-12. PubMed ID: 22019122 [TBL] [Abstract][Full Text] [Related]
12. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951 [TBL] [Abstract][Full Text] [Related]
13. Incorporating BCNU wafers into malignant glioma treatment: European case studies. Balossier A; Dörner L; Emery E; Heese O; Mehdorn HM; Menei P; Singh J Clin Drug Investig; 2010; 30(3):195-204. PubMed ID: 20155992 [TBL] [Abstract][Full Text] [Related]
14. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts. Marcantonio D; Panasci LC; Hollingshead MG; Alley MC; Camalier RF; Sausville EA; Dykes DJ; Carter CA; Malspeis L Cancer Res; 1997 Sep; 57(18):3895-8. PubMed ID: 9307267 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles. Han L; Ren Y; Long L; Zhong Y; Shen C; Pu P; Yuan X; Kang C Oncol Rep; 2012 Jan; 27(1):121-8. PubMed ID: 21922149 [TBL] [Abstract][Full Text] [Related]
16. Controlled quercetin release from high-capacity-loading hyperbranched polyglycerol-functionalized graphene oxide. Islami M; Zarrabi A; Tada S; Kawamoto M; Isoshima T; Ito Y Int J Nanomedicine; 2018; 13():6059-6071. PubMed ID: 30323593 [TBL] [Abstract][Full Text] [Related]
17. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer. Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961 [No Abstract] [Full Text] [Related]
18. BCNU-loaded poly(D, L-lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro. Seong H; An TK; Khang G; Choi SU; Lee CO; Lee HB Int J Pharm; 2003 Jan; 251(1-2):1-12. PubMed ID: 12527170 [TBL] [Abstract][Full Text] [Related]
19. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma. Nagpal S Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872 [TBL] [Abstract][Full Text] [Related]